[Prevention of hyperkalemia and muscular fasciculations induced by suxamethonium].
Suxamethonium has not yet been replaced to ease endotracheal intubation despite its many undesirable side effects. Hyperkalemia and muscle pain are two such side effects; they are not reliably prevented by giving, before suxamethonium, a small dose of a non depolarizing muscle relaxant, although it does decrease muscle fasciculations. The purpose of this study was to compare with a control group three different pretreatments of these undesirable effects of suxamethonium: 1) hyperventilation, 2) calcium chloride which are accepted means of lowering the serum potassium, and 3) magnesium sulfate which has been reported in a non-controlled study to decrease muscle fasciculations. The study was performed in 40 patients (10 per group) in whom changes of plasma potassium and calcium levels were determined and muscle fasciculations measured by an objective method. Serum electrolyte variations and the quantity and duration of muscle fasciculations were similar in all groups. None of the pretreatments administered had any adverse effect on the neuromuscular block induced by suxamethonium.
D000293:Adolescent; D000328:Adult; D002122:Calcium Chloride / Q000627:therapeutic use; D005207:Fasciculation / Q000139:chemically induced / Q000517:prevention & control*; D005260:Female; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced / Q000517:prevention & control*; D008278:Magnesium Sulfate / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009461:Neurologic Manifestations / Q000517:prevention & control*; D011188:Potassium / Q000097:blood; D012121:Respiration, Artificial / Q000379:methods; D013390:Succinylcholine / Q000009:adverse effects*
D008278:Magnesium Sulfate; D013390:Succinylcholine; D002122:Calcium Chloride; D011188:Potassium
Prophylaxie de l'hyperkaliémie et des fasciculations musculaires induites par le suxaméthonium.